Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Trial Profile

Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms ellipse II
  • Sponsors HRA Pharma
  • Most Recent Events

    • 30 Jul 2018 Status changed from recruiting to completed.
    • 06 Jun 2017 Planned End Date changed from 1 Apr 2015 to 1 Dec 2017.
    • 06 Jun 2017 Planned primary completion date changed from 1 Mar 2014 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top